Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)

SHA:603811 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	268.78	220.7	173.04	294.14	213.51	83.32
Cash & Short-Term Investments	268.78	220.7	173.04	294.14	213.51	83.32
Cash Growth	55.65%	27.55%	-41.17%	37.77%	156.25%	15.23%
Accounts Receivable	42.03	38.96	72.91	93.18	90.44	78.79
Other Receivables	19.65	1.56	6.47	2.87	1.28	1.33
Receivables	61.68	40.52	79.38	96.05	91.72	80.12
Inventory	116.72	116.34	131.84	116.78	111.04	117
Other Current Assets	17.13	17.92	9.36	10.45	20.57	7.35
Total Current Assets	464.31	395.49	393.62	517.42	436.84	287.8
Property, Plant & Equipment	892.15	891.23	945.69	1,003	919.65	668.66
Long-Term Investments	340.5	336.72	314.87	281.13	234.01	208.2
Goodwill	-	-	-	-	-	2.42
Other Intangible Assets	52.62	53.02	63.95	66.66	68.45	70.19
Long-Term Deferred Tax Assets	10.13	8	6.3	5.94	17.47	5.16
Long-Term Deferred Charges	0.15	0.2	0.41	1.43	1.44	2.24
Other Long-Term Assets	20.57	17.7	3.55	17.55	41.24	77.83
Total Assets	1,780	1,702	1,728	1,893	1,719	1,322

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	43.62	53.69	84.67	118.91	54.79	57.5
Accrued Expenses	22.17	131.87	78.28	76.15	79.75	72.57
Short-Term Debt	15	15.01	51.1	117.33	76.5	86.36
Current Portion of Long-Term Debt	17.05	17.04	40.43	8.91	14.02	-
Current Portion of Leases	-	-	0.02	0.75	0.61	0.76
Current Income Taxes Payable	30.47	13.87	6.4	-	-	7.83
Current Unearned Revenue	19.18	7.59	12.22	4.38	13.74	6.11
Other Current Liabilities	118.65	27.25	18.38	16.22	18.59	15.75
Total Current Liabilities	266.14	266.33	291.5	342.65	257.99	246.87
Long-Term Debt	23	5.7	139.31	316.38	334.77	59.63
Long-Term Leases	-	-	-	0.47	0.91	1.79
Long-Term Unearned Revenue	21.12	20.42	18.77	21.29	16.93	12.22
Long-Term Deferred Tax Liabilities	11.69	12.1	13.74	15.37	17.56	3.11
Total Liabilities	321.96	304.55	463.31	696.15	628.16	323.62

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	327.3	327.3	327.3	327.3	233.79	233.79
Additional Paid-In Capital	154.76	138.71	143	143	236.51	238.08
Retained Earnings	1,017	972.74	857.04	721.8	617.36	514.22
Treasury Stock	-48.29	-48.29	-67.26	-	-	-
Comprehensive Income & Other	-	-	-	0.21	0.23	0.22
Total Common Equity	1,451	1,390	1,260	1,192	1,088	986.31
Minority Interest	7.66	7.33	4.98	4.3	3.05	12.57
Shareholders' Equity	1,458	1,398	1,265	1,197	1,091	998.88
Total Liabilities & Equity	1,780	1,702	1,728	1,893	1,719	1,322

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	55.06	37.75	230.86	443.84	426.8	148.54
Net Cash (Debt)	213.73	182.95	-57.82	-149.7	-213.3	-65.22
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	0.48	0.41	-0.13	-0.33	-0.46	-0.14
Filing Date Shares Outstanding	444.76	444.76	446.45	458.23	458.23	458.23
Total Common Shares Outstanding	444.76	444.76	446.45	458.23	458.23	458.23
Working Capital	198.18	129.16	102.12	174.78	178.85	40.93
Book Value Per Share	3.26	3.13	2.82	2.60	2.37	2.15
Tangible Book Value	1,398	1,337	1,196	1,126	1,019	913.7
Tangible Book Value Per Share	3.14	3.01	2.68	2.46	2.22	1.99
Buildings	-	656.16	656.07	686.92	441.63	374.71
Machinery	-	681.75	672.02	687.58	600.01	443.66
Construction In Progress	-	30.71	5.15	6.16	182.6	99.91

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error